I just wanted to see if anyone else is following this stock. I have not bought it but got a referral from a friend. Lots of news and they are always doing something. Is anyone else looking at this?...
L-Ergothioneine is a Proprietary Nutraceutical Product Manufactured by Oxis International Inc.
Oxis International Inc. (OTCBB:OXIS), a biopharmaceutical company focused on commercializing...
FOSTER CITY, Calif.--(BUSINESS WIRE)--OXIS International Inc (OTCBB: OXIS), a biopharmaceutical company focused on commercializing predictive biomarkers, clinical assays and...
FOSTER CITY, Calif.--(BUSINESS WIRE)--OXIS International (OTCBB: OXIS; Nouveau Marche: OXIS) (FWB:
OXI), a biopharmaceutical company focused on commercializing predictive
biomarkers,...
FOSTER CITY, Calif.--(BUSINESS WIRE)--OXIS International (OTCBB: OXIS) (Nouveau Marche: OXIS) (FWB:
OXI), a biopharmaceutical company focused on commercializing biomarker
research and...
FOSTER CITY, Calif.--(BUSINESS WIRE)--OXIS International (OTCBB: OXIS) (Nouveau Marché:
OXIS) (FWB: OXI), a biopharmaceutical company focused on commercializing
research assays,...
FOSTER CITY, Calif.--(BUSINESS WIRE)--OXIS International, Inc. (OTCBB: OXIS) (Nouveau Marché:
OXIS) (FWB: OXI) commented today on an earlier announcement by Alteon
(Amex: ALT)...
FOSTER CITY, Calif.--(BUSINESS WIRE)--OXIS International, Inc. (OTCBB: OXIS) (Nouveau Marché:
OXIS) (FWB: OXI) today announced that Marvin S. Hausman, MD, the Company’s ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Sept. 21, 2006--OXIS International, Inc. (OTCBB:OXIS) (Nouveau Marche:OXIS) (FWB:OXI) announced today that Steve T. Guillen's employment as the President and...
PORTLAND, Ore.--(BUSINESS WIRE)--8 décembre 2005-- Cette acquisition élargit le portefeuille de produits et présente d'importantes opportunités pour de nouveaux produits dans...
PORTLAND, Ore.--(BUSINESS WIRE)--Dec. 8, 2005-- Acquisition Expands Product Portfolio and Drives Growth Opportunities for New Products in Cardiac Risk Assessment and Custom Assay Development...
PORTLAND, Ore.--(BUSINESS WIRE)--Nov. 15, 2005--OXIS International, Inc. (OTCBB:OXIS) (Nouveau Marche:OXIS) (FWB:OXI), specialists in developing technologies for the diagnosis of diseases resulting...